Xtane 25 mg Tablet contains exemestane, a steroidal aromatase inhibitor widely prescribed for the treatment of hormone receptor-positive breast cancer in postmenopausal women. Exemestane works by irreversibly inhibiting the aromatase enzyme, which is responsible for estrogen production in the body. By lowering estrogen levels, Xtane 25 mg Tablet helps prevent the growth and spread of estrogen-dependent cancer cells.

This oral anticancer medicine is commonly used as adjuvant therapy following initial treatment with tamoxifen or as part of long-term hormonal therapy in breast cancer management. Xtane 25 mg Tablet plays a crucial role in reducing the risk of cancer recurrence and improving disease-free survival when taken exactly as prescribed by an oncologist. As a prescription-only medicine, it ensures controlled and safe use under medical supervision.

Xtane 25 mg Tablet meets international quality and safety standards for oncology medicines. It is suitable for hospital use, specialty pharmacies, and export supply. Xtane 25 mg Tablet offers a reliable and effective hormonal treatment option for advanced and early-stage hormone-responsive breast cancer.

Product Features

• Contains Exemestane, a steroidal aromatase inhibitor
• Used in hormone-positive breast cancer treatment
• Helps lower estrogen production in postmenopausal women
• Oral tablet for convenient daily administration
• Often prescribed after tamoxifen therapy
• Prescription-only oncology medication

How It Helps

• Reduces estrogen levels by inhibiting the aromatase enzyme
• Slows or stops the growth of hormone-dependent breast cancer cells
• Lowers the risk of cancer recurrence after initial therapy
• Supports long-term management of breast cancer under medical care